Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A new mechanism for albuminuria-induced podocyte injury.

Literature DB >> 23990672

A new mechanism for albuminuria-induced podocyte injury.

Sandeep K Mallipattu¹, John C He.

Abstract

Entities: Disease

Mesh：

Substances：
Tretinoin

Year: 2013 PMID： 23990672 PMCID： PMC3810093 DOI： 10.1681/ASN.2013070714

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

× No keyword cloud information.

24 in total

1. ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo.

Authors: Michael R Vaughan; Jeffrey W Pippin; Siân V Griffin; Ron Krofft; Margaret Fleet; Leah Haseley; Stuart J Shankland
Journal: Kidney Int Date: 2005-07 Impact factor: 10.612

2. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

Authors:
Journal: Lancet Date: 1997-06-28 Impact factor: 79.321

3. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway.

Authors: John Cijiang He; Ting-Chi Lu; Margaret Fleet; Masaaki Sunamoto; Mohammad Husain; Wei Fang; Susana Neves; Yibang Chen; Stuart Shankland; Ravi Iyengar; Paul E Klotman
Journal: J Am Soc Nephrol Date: 2006-12-20 Impact factor: 10.121

4. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors: B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal: N Engl J Med Date: 2001-09-20 Impact factor: 91.245

5. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).

Authors: P Ruggenenti; A Perna; L Mosconi; M Matalone; R Pisoni; F Gaspari; G Remuzzi
Journal: Kidney Int Suppl Date: 1997-12 Impact factor: 10.545

6. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats.

Authors: Akira Suzuki; Takahito Ito; Enyu Imai; Masaya Yamato; Hirotsugu Iwatani; Hiroshi Kawachi; Masatsugu Hori
Journal: J Am Soc Nephrol Date: 2003-04 Impact factor: 10.121

7. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.

Authors: Kunitoshi Iseki; Kozen Kinjo; Chiho Iseki; Shuichi Takishita
Journal: Am J Kidney Dis Date: 2004-11 Impact factor: 8.860

A new mechanism for albuminuria-induced podocyte injury.

1. ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo.

2. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

3. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway.

4. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

5. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).

6. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats.

7. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.

8. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

Review 9. Retinoic acid in development: towards an integrated view.

10. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

Review 1. Nanomedicines for renal disease: current status and future applications.

2. APOL1-G1 in Nephrocytes Induces Hypertrophy and Accelerates Cell Death.

3. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.

4. Novel Role of Gestational Hydralazine in Limiting Maternal and Dietary Obesity-Related Chronic Kidney Disease.